Oct 13, 2013; Tampa, FL, USA; Tampa Bay Buccaneers guard Carl Nicks (77) watches from the sidelines during the first half against the Philadelphia Eagles at Raymond James Stadium. Mandatory Credit: Kim Klement-USA TODAY Sports

Tampa Bay Buccaneers Injury Update: Bad News for Carl Nicks and Rashaan Melvin

The Tampa Bay Buccaneers received two pieces of bad news on the injury front on Tuesday, as two players will be out for a prolonged period of time after a setback to a previous ailment.

The first is rookie corner Rashaan Melvin, who was moved to season-ending injured reserve after suffering a setback to his ailing hamstring. Melvin was a star during training camp, but struggled in the preseason before injuring his leg. The Buccaneers’ official website announced the news today. Losing Melvin further limits the depth in the Bucs’ defensive backfield, which has relied heavily on rookie Johnthan Banks and second-year corner Leonard Johnson.

The other injured player is highly paid guard Carl Nicks, who continues to battle a MRSA infection. Jenna Laine of Sports Talk Florida reports that Nicks will have surgery to clear out some of the infection from his foot. Nicks was back on the field after his initial diagnosis and treatment, but it has since been learned that the infection went into his bones, and it resurfaced this past week.

The interior of the Tampa Bay offensive line has been under fire all season, and being without Nicks won’t help matters at all. Gabe Carimi has been dealing with health issues of his own, and Ted Larsen and Jamon Meredith are not even remotely close to the talent that Carl Nicks is.

The injury status of Jeff Demps, who was hurt against the Eagles, is not yet known. No specifics are known about Da’Quan Bowers, who was seen in a walking boot on Monday.

Finally, Mike Williams is expected to return for Week 7’s game against the Falcons, according to the Tampa Bay Times.

Next Buccaneers Game Full schedule »
Sunday, Oct 2626 Oct1:00Minnesota VikingsBuy Tickets

Tags: Tampa Bay Buccaneers

comments powered by Disqus